Autism and Obsessive Compulsive Spectrum Program

Psychiatry Research Institute at Montefiore-Einstein (PRIME)

About the Director

Dr. Eric Hollander has been the PI of 10 federal grants, authored 560 publications, has 27,230 citations and an h-index of 92. He is Director of the International College of Obsessive Compulsive and Spectrum Disorders (ICOCS), and the Clinical TMS Society. He was chair of the DSM-5 Research Planning Agenda for Obsessive Compulsive and Related Disorders. He was director and PI of the NIH STAART Autism Center of Excellence, and PI of the NIMH Psychopharmacology Training Fellowship.

Dr. Hollander’s program has received funding from the Department of Defense, and the Orphan Products Division of FDA, for Autism, and Prader Willi Syndrome respectively. The program has developed targeted treatments for the repetitive behavior domain and the social communication domain of Autism Spectrum Disorder.



Autism and Obsessive Compulsive Spectrum Program
Psychiatry Research Institute at Montefiore-Einstein (PRIME)
1225 Morris Park Ave, Bronx, NY 10461
(718) 839-7530

For more information about any of our studies, please contact us using the information above.

The Autism and Obsessive Compulsive Spectrum Program at the Albert Einstein College of Medicine and Montefiore Medical Center is dedicated to three broad goals:

  1. Developing innovative, novel and breakthrough treatments for a unique group of overlapping conditions.
  2. Clarifying neurobiological mechanisms that underlie core symptom domains across these conditions.
  3. Providing world-class care to our research participants.

Our Autism and Obsessive Compulsive Spectrum Program currently focuses on Autism Spectrum Disorders (ASD) and Prader-Willi Syndrome (PWS). Obsessive Compulsive Spectrum Disorders such as Obsessive Compulsive Disorder (OCD), Body Dysmorphic Disorder (BDD), Intermittent Explosive Disorder (IED) and Tourette Syndrome (TS) is also of interest to the program.

The Autism and Obsessive Compulsive Spectrum Program is located at the Psychiatry Research Institute at Montefiore Einstein (PRIME) in the Van Etten Building of the Albert Einstein College of Medicine.


Key Collaborators

The program actively collaborates with the Einstein-Montefiore Institute for Clinical and Translational Research (ICTR) and other clinical investigators at Montefiore/Einstein.

The program has been awarded grant funding from the following organizations:

  • Department of Defense Autism Research Program
  • The Orphan Products Division of the Food and Drug Administration
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development, part of the National Institutes of Health
  • Foundation for Prader-Willi Research
  • Simons Foundation Autism Research Initiative (SFARI).

Our program has worked with the following industry sponsors: 

  • GW Pharmaceuticals
  • Sunovion Pharmaceuticals
  • F. Hoffmann-La Roche Ltd
  • Curemark LLC
  • Takeda
  • Avanir Pharmaceuticals
  • Neurocrine Biosciences
  • Pfizer
  • Forest Research Institute (now Allergan)
  • Transcept Pharmaceuticals
  • Coronado Biosciences
Click here to log in